The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells

This publication has 47 references indexed in Scilit:

• The Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Is an Antiestrogen-regulated Inhibitor of Cdk4 in Human Breast Cancer Cells
  Published by Elsevier ,2002
• Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function
  Molecular and Cellular Biology, 2001
• Inhibitory effect of p21 in MCF-7 cells is overcome by its coordinated stabilization with D-type cyclins
  Oncogene, 1999
• FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells
  Oncogene, 1998
• Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer Cells
  Published by Elsevier ,1998
• Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase
  Journal of Biological Chemistry, 1997
• Dephosphorylation of Cdk2 Thr ¹⁶⁰ by the Cyclin-Dependent Kinase-Interacting Phosphatase KAP in the Absence of Cyclin
  Science, 1995
• Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer
  Human Molecular Genetics, 1995
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
  Published by Elsevier ,1994
• p21 is a universal inhibitor of cyclin kinases
  Nature, 1993